SCCM Resource Library-Year in Review: Clinical Pharmacy and Pharmacology (Flipped Classroom)

Video Transcription

Video Summary

In summary, the updates in pulmonary diseases and the critically ill population in 2020 focused on the use of glucocorticoids or steroids. Studies have shown potential benefits of steroids in various respiratory conditions, including acute respiratory distress syndrome (ARDS) and COVID-19. Early treatment of ARDS with steroids has shown improvements in ventilator-free days and lung injury scores. However, there is also concern about potential harm, especially when steroids are used in late-stage ARDS. A study on dexamethasone in ARDS showed a significant improvement in mortality and other clinical outcomes. Similarly, a study from the Recovery Group found that dexamethasone reduced mortality in patients with COVID-19, especially those on mechanical ventilation. However, there are still questions about the optimal dose and timing of steroids in these populations. Future research should focus on phenotypes and inflammatory profiles to further understand the mechanism of action and determine which patients would benefit the most from steroids. Overall, steroids, especially dexamethasone, may be considered in patients with ARDS or COVID-19, but individualized treatment decisions should be made based on the patient's condition and characteristics.

Asset Subtitle

Neuroscience, Pharmacology, 2021

Asset Caption

The Society of Critical Care Medicine's Critical Care Congress features internationally renowned faculty and content sessions highlighting the most up-to-date, evidence-based developments in critical care medicine. This is a presentation from the 2021 Critical Care Congress held virtually from January 31-February 12, 2021.

Learning Objectives

Discuss the latest findings in neurocritical care pharmacotherapy
Describe management strategies for optimizing care of trauma patients
Evaluate and apply recent literature in the management of pulmonary diseases in critically ill patients

Mind Matters: Updates in Neurocritical Care
Casey C. May

Trauma Updates: The Blunt Truth
Jackie Johnston

A Breath of Fresh Air: New Updates in the Management of Pulmonary Diseases in the Critically Ill
Brittany D. Bissell

Meta Tag

Content Type Presentation

Knowledge Area Neuroscience

Knowledge Area Pharmacology

Knowledge Level Foundational

Knowledge Level Intermediate

Knowledge Level Advanced

Membership Level Select

Tag Coagulation

Tag Neurotrauma

Tag Blood and Blood Substitutes

Year 2021

Keywords

pulmonary diseases

glucocorticoids

steroids

ARDS

COVID-19

ventilator-free days

dexamethasone

mortality

mechanical ventilation

Neuroscience

Pharmacology

Coagulation

Neurotrauma

Presentation

Select

2021

Blood Blood Substitutes

Foundational

Intermediate

Advanced

Blood and Blood Substitutes

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.